VRSN.NASDAQVerisign Inc/ca

Form 4: VeriSign Executive Chairman Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold a total of 8,750 shares of common stock over several transactions in early September 2025 under a Rule 10b5-1 plan.

Summary

  • D. James Bidzos, VeriSign's Executive Chairman, President, and CEO, reported the sale of 8,750 shares of common stock.
  • These transactions occurred over three trading days: September 9, 10, and 11, 2025.
  • The sales were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
  • The shares were sold at weighted average prices ranging from $280.8236 to $290.18 per share.
  • Following these transactions, Bidzos's direct beneficial ownership decreased from 493,188.7009 shares to 485,438.7009 shares.
  • The reported beneficial ownership includes 134.7365 dividend equivalent restricted stock units acquired on August 27, 2025, under the Company's Amended and Restated 2006 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing reports routine insider sales by a key executive under a pre-arranged 10b5-1 plan, which is generally not considered a strong signal for future stock performance and does not provide new information about the company's operational or financial health.

Positives

  • The sales were conducted under a Rule 10b5-1 plan, which suggests a pre-arranged, non-discretionary trading strategy rather than opportunistic selling.
  • The reporting person acquired 134.7365 dividend equivalent restricted stock units on August 27, 2025, indicating continued equity participation and alignment with shareholder interests.

Negatives

  • The Executive Chairman, President, and CEO reduced his direct beneficial ownership by 8,750 shares, which represents a decrease in direct insider holdings.

Future Outlook

Not applicable. This Form 4 filing reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

Not applicable. This Form 4 filing reports individual insider transactions and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership, which is generally a neutral event when conducted under a 10b5-1 plan, as it indicates pre-planned diversification rather than a reaction to new negative information.

Key Dates

DateDescription
08/27/2025Acquisition of 134.7365 dividend equivalent restricted stock units.
09/09/2025Sale of 1,250 shares of common stock at $280.8236.
09/09/2025Sale of 950 shares of common stock at $282.2756.
09/09/2025Sale of 764 shares of common stock at $283.113.
09/09/2025Sale of 600 shares of common stock at $284.1075.
09/09/2025Sale of 1,436 shares of common stock at $285.6795.
09/10/2025Sale of 1,600 shares of common stock at $283.4145.
09/10/2025Sale of 200 shares of common stock at $284.88.
09/10/2025Sale of 200 shares of common stock at $286.46.
09/11/2025Sale of 200 shares of common stock at $284.77.
09/11/2025Sale of 400 shares of common stock at $286.68.
09/11/2025Sale of 845 shares of common stock at $287.756.
09/11/2025Sale of 455 shares of common stock at $289.1185.
09/11/2025Sale of 100 shares of common stock at $290.18.

Recommendation

hold

The filing reports routine insider sales by a key executive under a pre-arranged 10b5-1 plan. This type of transaction is generally not considered a strong signal for future stock performance and does not provide new information about the company's operational or financial health. Therefore, a 'hold' recommendation is appropriate as this filing alone does not alter the fundamental investment thesis.

Keywords

VeriSign, VRSN, Insider Trading, Form 4, Stock Sale, D. James Bidzos, Executive Chairman, CEO, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.